ES2109993T3 - Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables. - Google Patents

Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables.

Info

Publication number
ES2109993T3
ES2109993T3 ES92903714T ES92903714T ES2109993T3 ES 2109993 T3 ES2109993 T3 ES 2109993T3 ES 92903714 T ES92903714 T ES 92903714T ES 92903714 T ES92903714 T ES 92903714T ES 2109993 T3 ES2109993 T3 ES 2109993T3
Authority
ES
Spain
Prior art keywords
desoxi
pharmaceutically acceptable
epipodofilotoxina
derivatives
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92903714T
Other languages
English (en)
Spanish (es)
Inventor
Tadafumi Terada
Katsuhiko Fujimoto
Makoto Nomura
Junichi Yamashita
Setsuo Takeda
Takashi Kobunai
Hideo Yamaguchi
Konstanty Wierzba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2109993T3 publication Critical patent/ES2109993T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Tea And Coffee (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES92903714T 1991-01-25 1992-01-22 Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables. Expired - Lifetime ES2109993T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8714091 1991-01-25
JP6170691 1991-03-26
JP9079491 1991-04-22

Publications (1)

Publication Number Publication Date
ES2109993T3 true ES2109993T3 (es) 1998-02-01

Family

ID=27297605

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92903714T Expired - Lifetime ES2109993T3 (es) 1991-01-25 1992-01-22 Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables.

Country Status (17)

Country Link
US (3) US5489698A (en:Method)
EP (1) EP0522173B1 (en:Method)
JP (1) JP2631912B2 (en:Method)
KR (1) KR0145338B1 (en:Method)
CN (2) CN1035821C (en:Method)
AT (1) ATE159258T1 (en:Method)
AU (1) AU636076B2 (en:Method)
CA (1) CA2078662C (en:Method)
DE (1) DE69222698T2 (en:Method)
DK (1) DK0522173T3 (en:Method)
ES (1) ES2109993T3 (en:Method)
FI (1) FI101227B1 (en:Method)
HU (1) HU211961A9 (en:Method)
NO (1) NO301277B1 (en:Method)
RU (1) RU2074185C1 (en:Method)
TW (1) TW221441B (en:Method)
WO (1) WO1992012982A1 (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021511A1 (en) * 1993-03-13 1994-09-29 Philip Anton Strong A transfer system
GB2290524B (en) * 1993-03-13 1997-03-12 Philip Anton Strong A transfer system
US6380394B1 (en) * 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
EP1067933B1 (en) * 1998-04-06 2007-08-15 The Board Of Trustees Of The University Of Illinois Semi-synthetic ecteinascidins
CA2331593C (en) * 1998-05-11 2008-08-05 Pharma Mar, S.A. Metabolites of ecteinascidin 743
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
CN1101819C (zh) * 1999-10-21 2003-02-19 国家医药管理局上海医药工业研究院 具有抗肿瘤活性的4－β－碳取代－4－脱氧－4'－去甲表鬼臼毒素衍生物及合成方法和中间体
EP1325152A2 (en) 2000-07-14 2003-07-09 F. Hoffmann-La Roche Ag Method for detecting pre-disposition to hepatotoxicity
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US7176236B2 (en) * 2002-06-21 2007-02-13 University Of North Carolina At Chapel Hill Water-soluble etoposide analogs and methods of use thereof
US6566393B1 (en) * 2002-06-21 2003-05-20 The University Of North Carolina At Chapel Hill Etoposide analogs and methods of use thereof
TWI307341B (en) * 2002-10-11 2009-03-11 Plantaceutica Inc Anticancer compounds
FR2859208B1 (fr) * 2003-09-02 2006-01-21 Servier Lab Nouveaux derives de 9-amino-podophyllotoxine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
GB0514685D0 (en) * 2005-07-19 2005-08-24 Pharma Mar Sa A ntineoplastic compounds
FR2935143B1 (fr) * 2008-08-19 2010-12-03 Pf Medicament Nouveaus derives (poly)aminoalkylaminoalkylamides, alkyl-urees, ou alkyl-sulfonamides d'epipodophyllotoxine, leur procede de preparation et leur application en therapeuthique comme agent cancereux
JP2013530993A (ja) 2010-07-02 2013-08-01 アンジオケム インコーポレーテッド 治療用コンジュゲートのための短く且つｄ−アミノ酸を含有するポリペプチドおよびその使用
ES2621966T3 (es) 2010-08-31 2017-07-05 Axelar Ab Nuevo procedimiento de preparación de ciclolignanos
CN103613600B (zh) 2013-11-15 2017-01-04 湖北工业大学 具抗肿瘤活性的苯胺基鬼臼类衍生物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103883A (ja) * 1984-10-24 1986-05-22 Nippon Kayaku Co Ltd ４′−ハロゲノアセチル−４′−デメチルエピポドフイロトキシンの新規製造法
JPS6310789A (ja) * 1986-07-01 1988-01-18 Nippon Kayaku Co Ltd 新規ポドフイロトキシン誘導体
JPH01117885A (ja) * 1987-10-30 1989-05-10 Dai Ichi Seiyaku Co Ltd 新規ボドフィロトキシン誘導体及びその製造法
JPH01267855A (ja) * 1988-04-19 1989-10-25 Canon Inc 光学情報記録媒体
JPH02191279A (ja) * 1988-10-26 1990-07-27 Warner Lambert Co ４‐ブロモ‐４′‐デメチルエピポドフイロトキシンおよびその新規な誘導体の製法
ATE186302T1 (de) * 1989-02-23 1999-11-15 Univ North Carolina Etoposidanaloge
JP2587705B2 (ja) * 1989-10-12 1997-03-05 大鵬薬品工業株式会社 ４―デソキシ―４―エピポドフィロトキシン誘導体
JP2001127792A (ja) * 1999-10-22 2001-05-11 Wittei:Kk 逐次処理によるネットワーク通信

Also Published As

Publication number Publication date
CN1035821C (zh) 1997-09-10
US5571914A (en) 1996-11-05
NO923721D0 (no) 1992-09-24
DE69222698D1 (de) 1997-11-20
FI924285L (fi) 1992-09-24
FI101227B (fi) 1998-05-15
CA2078662C (en) 2000-04-04
EP0522173A4 (en) 1993-06-16
CN1064278A (zh) 1992-09-09
DE69222698T2 (de) 1998-05-20
WO1992012982A1 (en) 1992-08-06
ATE159258T1 (de) 1997-11-15
RU2074185C1 (ru) 1997-02-27
KR0145338B1 (ko) 1998-07-15
HU211961A9 (en) 1996-01-29
DK0522173T3 (da) 1998-03-09
NO301277B1 (no) 1997-10-06
FI101227B1 (fi) 1998-05-15
AU1180592A (en) 1992-08-27
NO923721L (no) 1992-11-23
US5536847A (en) 1996-07-16
EP0522173A1 (en) 1993-01-13
TW221441B (en:Method) 1994-03-01
US5489698A (en) 1996-02-06
CA2078662A1 (en) 1992-07-26
FI924285A0 (fi) 1992-09-24
AU636076B2 (en) 1993-04-08
JP2631912B2 (ja) 1997-07-16
CN1046521C (zh) 1999-11-17
CN1126723A (zh) 1996-07-17
EP0522173B1 (en) 1997-10-15

Similar Documents

Publication Publication Date Title
ES2109993T3 (es) Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables.
ES2135372T3 (es) Derivados del acido piridonacarboxilico opticamente activos.
ES2171416T3 (es) Remedio contra la trombocitopenia.
ES2160693T3 (es) Formulacion estable de 10-hidroxi-7-etil-camptotecina en la forma lactona.
ES2104889T3 (es) Derivado de 6-o-metileritromicina a.
ES2156155T3 (es) Derivado de pirazol.
ES2159591T3 (es) Composicion de liberacion controlada.
ES2062691T3 (es) Derivados hidrogenados de la rapamicina.
NO933854L (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
ES2182852T3 (es) Derivados de prolinamida.
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
ES2055860T3 (es) Derivados 2-aminopirimidinona.
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
DE69322251D1 (de) Medizinische zusammensetzung
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
ES2173883T3 (es) Utilizacion de derivados de piperacina-acetamida contra los daños de reperfusion.
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
ES2160834T3 (es) Derivado de fenil pirimidina opticamente activo como agente analgesico.
ES2072386T3 (es) Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b.
ES2099828T3 (es) Derivado aminoacido.
MX9305523A (es) Composiciones quimoterapeuticas mejoradas frente a infecciones microbianas en peces, la reparacion y uso de las mismas.
ATE316788T1 (de) Medikament gegen pulmonale herzprobleme
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 522173

Country of ref document: ES